Takara Bio, Chinese CDC to Collaborate in AIDS Research.Tokyo, Japan, June 20, 2006 - (JCN) - Takara Bio announced on June 19 that it has reached an agreement with the Chinese Center for Disease Control and Prevention (Chinese CDC) to collaborate in research on Acquired Immune Deficiency immune deficiency n. Syndrome (AIDS). See immunodeficiency common variable immunodeficiency (CVID) a heterogeneous group of disorders characterized by hypogammaglobulinemia, decreased antibody production, and recurrent pyogenic infections, and often associated with hematologic and autoimmune disorders. Most patients appear to have an intrinsic defect of B cell differentiation.. The two partners will strive to confirm the efficacy of AIDS gene therapy using RNA interference RNA interference n. enzymes. The gene therapy is intended to destroy RNA in Human Immunodeficiency Virus (HIV). Specifically, the partners will conduct validation experiments using simian simian /sim·i·an/ (sim´e-an) of, pertaining to, or resembling an ape or a monkey. T-cells and Simian Immune Deficiency Virus (SIV SIV - Safety Interlocks Valid A process in which the introduction of double-stranded RNA into a cell inhibits the expression of genes. SIV - Self-Inflicted Violence SIV - Setto Interventricolare (Italian) SIV - Silo Interface Vault (missile defense) SIV - Simian Immunodeficiency Virus SIV - Site Initiation Visit SIV - Situs Inversus Viscerum SIV - Small Islands Voice SIV - Sorry I Vanished (chat) SIV - special interest vessel (US DoD) SIV - Speed Increase Valve SIV - Structured Investment Vehicle SIV - Swine Influenza Virus). Since 1981, over 25 million people have died of AIDS. Currently, it is estimated that over 40 million people are infected with HIV, of which about 8 million people reside in Asia. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion